Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Zeltia SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

31 Oct 2015 Reuters Investment Profile 12 $20.00

Zeltia, S.A. (ZEL) - Financial Analysis Review

Zeltia, S.A. (ZEL) - Financial Analysis Review Summary Zeltia, S.A. (Zeltia) is a biopharmaceutical company that discovers an...

20 Jan 2016 GlobalData 37 $300.00

Zeltia, S.A. (ZEL) - Financial Analysis Review

Zeltia, S.A. (ZEL) - Financial Analysis Review Summary Zeltia, S.A. (Zeltia) is a biopharmaceutical company that discovers an...

15 Dec 2015 GlobalData 44 $300.00

ZELTIA - FDA APPROVES YONDELIS IN SOFT TISSUE SARCOMA

The US FDA has approved Zeltia’s Yondelis (trabectedin) for the treatment of soft tissue sarcomas (STS) liposarcoma and leiom...

27 Oct 2015 Edison Investment Research 1 $10.00

Wright Investors Service Comprehensive Report for Zeltia SA

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

23 Oct 2015 Wright Reports 56 $75.00

Zeltia, S.A. (ZEL) - Financial Analysis Review

Zeltia, S.A. (ZEL) - Financial Analysis Review Summary Zeltia, S.A. (Zeltia) is a biopharmaceutical company that discov...

25 Sep 2015 GlobalData 30 $125.00

Zeltia SA: Downgraded to Risky

02 Sep 2015 Sadif Analytics Prime 3 $10.00

Zeltia SA: Downgraded to Risky

04 Jun 2015 Sadif Analytics Prime 3 $10.00

Zeltia, S.A. (ZEL) - Financial Analysis Review

Zeltia, S.A. (ZEL) - Financial Analysis Review Summary Zeltia, S.A. (Zeltia) is a pharmaceutical holding company. It op...

14 May 2015 GlobalData 29 $125.00

Is Zeltia SA Worth a Higher Bid?

05 May 2015 Sadif Analytics Prime 12 $25.00